Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H26N2O2.ClH |
Molecular Weight | 398.926 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C4=CC=CC=C4
InChI
InChIKey=XSOOSXRNMDUWEM-GNAFDRTKSA-N
InChI=1S/C23H26N2O2.ClH/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18;/h1-10,20H,11-17H2,(H,24,26,27);1H/t23-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C23H26N2O2 |
Molecular Weight | 362.4647 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Dexetimide is a potent central and peripheral anticholinergic agent. It has a high affinity for all subtypes of muscarinic receptor and a long duration action. It forms very stable complex with mAChR. Dexetimide was used for many years in Europe for the treatment of extrapyramidal disorders. Neuroleptic-induced parkinsonian symptoms are effectively controlled by dexetimide. It is a safe, potent, and long-acting antiparkinsonian agent.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent. | 1971 |
|
Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action. | 1973 Jul-Aug |
|
Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists. | 1985 Dec |
|
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. | 1998 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1020682
Dosages ranged from 0.5 to 1.5 mg daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:03 UTC 2023
by
admin
on
Fri Dec 15 15:20:03 UTC 2023
|
Record UNII |
B987A3XX7D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT002920
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
B987A3XX7D
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
SUB23576
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
244-633-2
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
259361
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | RxNorm | ||
|
30842
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
m4217
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID50944485
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
21888-96-0
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY | |||
|
100000089082
Created by
admin on Fri Dec 15 15:20:03 UTC 2023 , Edited by admin on Fri Dec 15 15:20:03 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
RACEMATE -> ENANTIOMER |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |